Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies

View source ↗

Summary

This clinical trial update explains the concept of a durable effect for B-cell modulating therapies in relapsing-remitting multiple sclerosis and its potential …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • B-cell modulating therapies (unspecified)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Relapsing-remitting Multiple Sclerosis | Status: RECRUITING